CAS No.30748-29-9,Feprazone Suppliers

Products Categories

Pharmaceutical (51)
Organic Chemicals (20)
Others (5)
Reagent (3)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	30748-29-9
Name:	Feprazone

Formula:	C₂₀H₂₀N₂O₂
Molecular Weight:	320.391
Synonyms:	4-(2-Isopentenyl)-1,2-diphenyl-3,5-pyrazolidinedione;4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione;4-Prenyl-1,2-diphenyl-3,5-dioxopyrazolidine;4-Prenyl-1,2-diphenyl-3,5-pyrazolidinedione;Analud;DA 2370;Methrazone;Metrazone;Phenylprenazone;Pheprazone;Prenazone;Zepelin;
EINECS:	250-324-3
Density:	1.175 g/cm³
Melting Point:	156.5° (ethanol)
Boiling Point:	437.197 °C at 760 mmHg
Flash Point:	178.698 °C
PSA:	40.62000
LogP:	4.08390

Country:
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:67 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 30748-29-9

Specification

The 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione with the cas number 30748-29-9, is also called (1) 1,2-Diphenyl-4-(3-methyl-2-butenyl)-3,5-pyrazolidinedione; (2) 3,5-Pyrazolidinedione, 4-(3-methyl-2-butenyl)-1,2-diphenyl- ; (3) 4-(2-Isopentenyl)-1,2-diphenyl-3,5-pyrazolidinedione ; (4) 4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione ; (5) 4-(beta-Isoamylenyl)-1,2-diphenyl-3,5-pyrazolidinedione ; (6) 4-Prenyl-1,2-diphenyl-3,5-dioxopyrazolidine ; (7) 4-Prenyl-1,2-diphenyl-3,5-pyrazolidinedione ; (8) Analud ; (9) Fenilprenazone ; (10) Feprazona ; (11) Feprazona [INN-Spanish] ; (12) Feprazone ; (13) Feprazonum ; (14) Feprazonum [INN-Latin] ; (15) Methrazone ; (16) Phenylprenazone ; (17) Pheprazone ; (18) Prenazone ; (19) UNII-7BVX6J0CGR ; (20) Zepelin

Properties of 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione are: (1)ACD/BCF (pH 5.5): 163.78 ; (2)ACD/BCF (pH 7.4): 7.64 ; (3)ACD/KOC (pH 5.5): 1215.59 ; (4)ACD/KOC (pH 7.4): 56.68 ; (5)#H bond acceptors: 4 ; (6)#H bond donors: 0 ; (7)#Freely Rotating Bonds: 4 ; (8)Polar Surface Area: 40.62Å² ; (9)Index of Refraction: 1.599 ; (10)Molar Refractivity: 93.24 cm³ ; (11)Molar Volume: 272.7 cm³ ; (12)Polarizability: 36.96× 10^-24cm³ ; (13)Surface Tension: 46.8 dyne/cm ; (14)Density: 1.174 g/cm³; (15)Flash Point: 178.7 °C ; (16)Enthalpy of Vaporization: 69.38 kJ/mol ; (17)Boiling Point: 437.2 °C at 760 mmHg ; (18)Vapour Pressure: 7.62E-08 mmHg at 25°C

The 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione is applicable for treat with rheumatoid arthritis, rheumatoid arthritis, ankylosing arthritis, scapulohumeral periarthritis, thrombophlebitis, Myofibrositis, dentinum phlogosis, sciatica, etc. There may be side effect such as rash, drowsiness, edema, etc, and the one who with liver and kidney damage.

You can still convert the following datas into molecular structure :
1. SMILES: O=C2N(c1ccccc1)N(C(=O)C2C\C=C(/C)C)c3ccccc3
2. InChI: InChI=1/C20H20N2O2/c1-15(2)13-14-18-19(23)21(16-9-5-3-6-10-16)22(20(18)24)17-11-7-4-8-12-17/h3-13,18H,14H2,1-2H3

The 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione toxic data can be showed in the following sheet.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	oral	> 2gm/kg (2000mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH	Yakkyoku. Pharmacy. Vol. 33, Pg. 233, 1982.
mouse	LD50	intraperitoneal	270mg/kg (270mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
mouse	LD50	intravenous	180mg/kg (180mg/kg)		Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 196, 1972.
mouse	LD50	oral	1067mg/kg (1067mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 196, 1972.
mouse	LDLo	subcutaneous	374mg/kg (374mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
rat	LD50	intraperitoneal	362mg/kg (362mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
rat	LD50	oral	1343mg/kg (1343mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
rat	LD50	subcutaneous	386mg/kg (386mg/kg)		Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 20, Pg. 267, 1985.